Gene · 59341
Papers4,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transforming destructive mechanical cues into therapeutic power: Activation of PIEZO1 and TRPV4 counteracts mechano-induced damage of cellular junctions in Hailey-Hailey disease. | J Adv Res | 2026 | 41314280 | PubTator, text mining | PubMed |
| Evidence-based classification of genes implicated in skeletal disorders using the ClinGen curation framework. | J Bone Miner Res | 2026 | 41313243 | PubTator, text mining | PubMed |
| Genetic analysis in fetuses with isolated clubfoot: diagnostic insights and added value. | Eur J Hum Genet | 2026 | 41272104 | PubTator, text mining | PubMed |
| Expanding the Genotype and Phenotype Diversity in a Chinese Cohort With TRPV4-Related Dysplasia. | Clin Genet | 2026 | 41263626 | PubTator, text mining | PubMed |
| KAT6A regulates osteoclast differentiation and bone resorption through TET1-mediated TRPV4 expression. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 41175189 | PubTator, text mining | PubMed |
| Modulation of cellular and mitochondrial dysfunction by TRPV4 during early stages of Vincristine-induced neurotoxicity in cultured neuronal model. | Neuropharmacology | 2026 | 41072722 | PubTator, text mining | PubMed |
| TRPV4 is involved in progesterone-mediated sexual dimorphism in mesenchymal stem cell functions and bio-mineralization. | Biochim Biophys Acta Mol Cell Res | 2026 | 41022257 | PubTator, text mining | PubMed |
| A Novel Core-Shell Hydrogel 3D Model for Studying Macrophage Mechanosensing and Foreign Body Giant Cell Formation. | Adv Healthc Mater | 2026 | 40974126 | PubTator, text mining | PubMed |
| Brain Capillary Ion Channels: Physiology and Channelopathies. | Physiology (Bethesda) | 2026 | 40748720 | PubTator, text mining | PubMed |
| A bibliometric study of the most-cited research articles and reviews in Naunyn-Schmiedeberg's Archives of Pharmacology (1969-2024). | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 40748476 | PubTator, text mining | PubMed |
| Decreased Transient Receptor Potential Channel mRNA Expression in the Aortas of Patients with Hypertension. | Anatol J Cardiol | 2026 | 40454880 | PubTator, text mining | PubMed |
| Interplay between extracellular matrix mechanics and cell function in mechanobiology. | Curr Opin Biomed Eng | 2025 | 42006117 | PubTator, text mining | PubMed |
| Understanding Fascial Tissue on the Molecular Level-How Its Unique Properties Enable Adaptation or Dysfunction. | Int J Mol Sci | 2025 | 41516037 | PubTator, text mining | PubMed |
| Integration of cAMP and TRPV4 Signaling to Optimize Collagen Remodeling for Management of Fibrosis. | Cells | 2025 | 41511340 | PubTator, text mining | PubMed |
| [Screening and mechanisms of action of anti-SARS-CoV-2 traditional Chinese medicine monomer compounds targeting TRPV4]. | Zhongguo Zhong Yao Za Zhi | 2025 | 41507756 | PubTator, text mining | PubMed |
| Bioinformatic Approach to Identify Potential TGFB2-Dependent and Independent Prognostic Biomarkers for Ovarian Cancers Treated with Taxol. | Int J Mol Sci | 2025 | 41465326 | PubTator, text mining | PubMed |
| TRPV4 Orchestrates Distinct Calcium and Cell Growth Responses in Non-Tumorigenic and Clear Cell Renal Carcinoma-Derived Cells. | J Cell Physiol | 2025 | 41457365 | PubTator, text mining | PubMed |
| Downregulation of TRPV4 and LRRC8A in Crystalline Lenses of Diabetic Patients May Contribute to Cataractogenesis. | Clin Ophthalmol | 2025 | 41438159 | PubTator, text mining | PubMed |
| Lysophosphatidylcholine sensitizes TRPV2 by indirect mechanisms. | Pflugers Arch | 2025 | 41381750 | PubTator, text mining | PubMed |
| Immunity in motion: The role of mechanics in macrophage biology. | Cell Chem Biol | 2025 | 41371224 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/59341/papers?page=10